San Carlos, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Addario Lung Cancer Medical Institute, founded in 2008, is a community nonprofit in the Medical Research sector that reported $1.9M in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. The organization ran a surplus of $329K, a strong 17% operating margin.
The Addario Lung Cancer Medical Institute ALCMI is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients.
Research - The Addario Lung Cancer Medical Institute (ALCMI) is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung...
Research - The Addario Lung Cancer Medical Institute (ALCMI) is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients. ALCMI is a patient-founded, patient-focused research consortium. Its goal is to make lung cancer a chronically managed disease. ALCMI was created in 2008 to enable the collection and analysis of tissue and blood samples which are essential to research and to the development of individually tailored (and more effective) therapies. ALCMI is also a comprehensively contracted consortium with shared infrastructures (standardized contracts, data systems and biorepositories) and centrally coordinated scientific planning. Cont'd. at Schedule O
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,914,034 | $1,553,569 | +0.2% |
| Expenses | $1,585,224 | $1,112,960 | +0.4% |
| Net Income | $328,810 | $440,609 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Richard Erwin | Sr. Dir. Clinical Operations | 40.00 |
|
$221,088 | $9,783 | $230,871 |
| Tony Addario Chair | CEO | 40.00 |
Officer
Director
|
$0 | $0 | $0 |
| Ken Krantz | CEO | 40.00 |
Officer
Director
|
$0 | $0 | $0 |
| Bonnie Addario | Director | 5.00 |
Director
|
$0 | $0 | $0 |
| Bruce Gellman | Director | 0.46 |
Director
|
$0 | $0 | $0 |
| Gary Ingenito | Director | 0.46 |
Director
|
$0 | $0 | $0 |
| Steve Cavan Treasurer | Director | 0.46 |
Director
|
$0 | $0 | $0 |
| Tom Krohn RPh MBA | Director | 0.46 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,914,034 | $1,585,224 | $2,244,730 | $328,810 |
| 2023 | $1,553,569 | $1,112,960 | $1,490,643 | $440,609 |
| 2022 | $1,061,978 | $987,672 | $1,003,534 | $74,306 |
| 2021 | $1,553,644 | $1,086,366 | $1,036,268 | $467,278 |
| 2020 | $919,609 | $943,930 | $578,817 | $-24,321 |
| 2019 | $987,238 | $977,138 | $472,232 | $10,100 |
| 2018 | $1,516,110 | $1,192,998 | $465,281 | $323,112 |
Compare Addario Lung Cancer Medical Institute with other nonprofits in California and across the country.